0001354488-14-000395.txt : 20140130
0001354488-14-000395.hdr.sgml : 20140130
20140130143013
ACCESSION NUMBER: 0001354488-14-000395
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140130
FILED AS OF DATE: 20140130
DATE AS OF CHANGE: 20140130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000830656
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042652826
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
BUSINESS PHONE: 5082301828
MAIL ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
FORMER COMPANY:
FORMER CONFORMED NAME: BOSTON BIOMEDICA INC
DATE OF NAME CHANGE: 19960812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mangiardi Vito J
CENTRAL INDEX KEY: 0001339044
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21615
FILM NUMBER: 14560370
MAIL ADDRESS:
STREET 1: 12 POINT GALLINAS ROAD
CITY: SAN RAFAEL
STATE: CA
ZIP: 94903
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2014-01-30
0
0000830656
PRESSURE BIOSCIENCES INC
PBIO
0001339044
Mangiardi Vito J
12 POINT GALLINAS ROAD
SAN RAFAEL
CA
94903
1
Series K Convertible Preferred Stock
.25
2014-01-30
4
P
0
90
A
2014-01-30
2015-01-30
Common Stock
90000
90000
D
Series K Common Stock Purchase Warrant
.3125
2014-01-30
4
P
0
45000
A
2014-01-30
2017-01-30
Common Stock
45000
45000
D
The terms of the Series K Convertible Preferred Stock contain a limitation on conversion which prevents the Reporting Person from converting shares of Series K Convertible Preferred Stock if, after giving effect to the conversion, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99%, or 19.99% upon not less than 61 days prior written notice to the Company. Since the Reporting Person currently beneficially owns less than 4.99% of the outstanding shares of Common Stock, the conversion limitation that applies to the Reporting Person is the 4.99% limitation. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities.
Pursuant to a certain Securities Purchase Agreement dated December 12, 2013, among the Company, the Reporting Person, and the other purchasers named therein, the Reporting Person purchased 90 "Units" at a purchase price of $250 per Unit. Each Unit consisted of (i) one share of Series K Convertible Preferred Stock, convertible into 1,000 shares of the Company's Common Stock, and (ii) a warrant to purchase 500 shares of Common Stock, which warrant is exercisable until December 12, 2016.
The Series K Common Stock Purchase Warrants contain a limitation on exercise which prevents the Reporting Person from exercising any Warrants if, after giving effect to the exercise, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99%, or 19.99% upon not less than 61 days prior written notice to the Company. Since the Reporting Person currently beneficially owns less than 4.99% of the outstanding shares of Common Stock, the exercise limitation that applies to the Reporting Person is the 4.99% limitation. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities
/s/
2014-01-30